Latest news with #DiMeSeal
Associated Press
03-06-2025
- Business
- Associated Press
2Morrow Awarded DiMe Seal, Recognized for Excellence in Digital Behavior Change
'At 2Morrow, we believe that behavior change tools should be grounded in science, accessible to all, and built to scale. This recognition challenges all of us to keep raising the bar.'— Jo Masterson, CEO of 2Morrow KIRKLAND, WA, UNITED STATES, June 3, 2025 / / -- 2Morrow has been named a recipient of the DiMe Seal, a new standard of excellence developed by the Digital Medicine Society (DiMe) in collaboration with Elevance Health. The Seal recognizes digital health software products that meet rigorous standards for clinical strength, usability, privacy, and equity. With over 337,000 digital health apps available globally, the need for clarity and quality assurance has never been greater. The DiMe Seal was created to provide healthcare leaders with a trusted signal, identifying solutions that are not only innovative, but also backed by meaningful evidence and ready for real-world impact. 'The DiMe Seal is helping redefine how digital health earns trust,' said Jo Masterson, CEO of 2Morrow. 'We're proud to be part of this movement toward greater transparency and rigor. At 2Morrow, we believe that behavior change tools should be grounded in science, accessible to all, and built to scale. This recognition affirms that approach and challenges all of us to keep raising the bar.' Elevating Evidence-Based Digital Care 2Morrow's Breathe Bundle - which includes programs for tobacco cessation, stress, weight, and personal goal setting - is the only multi-program solution of its kind recognized in the inaugural DiMe Seal cohort. Designed to support behavior change at scale, the programs are grounded in evidence-based approaches and principles drawn from Acceptance and Commitment Therapy (ACT). As part of the evaluation process, which included independent review and clinical input from Elevance Health, one of the nation's largest payers, 2Morrow received a 'Strong' recommendation for its clinical evidence. The assessment highlighted randomized trial results, a transparent evidence base, and strong usability across a broad range of populations. Building a More Trusted Future in Digital Health 2Morrow is proud to be among the first companies to earn this designation and to stand alongside a diverse group of innovators working to define quality in digital health. According to the IQVIA Digital Health Trends 2024 report, only a small fraction of digital health solutions offer published evidence of clinical impact, making initiatives like the DiMe Seal increasingly vital to helping healthcare leaders make confident, informed decisions. 'The influx of innovative digital health software products in our healthcare system can transform how we deliver care, but healthcare leaders need a clear, reliable way to identify which solutions are ready to deliver impact,' said Doug Mirsky, Vice President, DiMe Seal. 'The DiMe Seal offers that clarity, and we're proud to help elevate organizations like 2Morrow that are building products that exemplify the evidence-backed, scalable innovation the healthcare system needs.' The DiMe Seal reflects a broader shift across the healthcare ecosystem: a demand for solutions that don't just promise change, but can prove it. For organizations seeking digital programs that are practical, proven, and ready to implement, the Seal provides a new level of confidence. Learn more about the DiMe Seal here. About 2Morrow: 2Morrow is a leading provider of evidence-based digital behavioral health and wellness solutions, including tobacco cessation. Our efforts in assisting people to quit smoking have consistently yielded positive outcomes, supported by a Phase III randomized controlled trial involving 2,400 participants and more than 12 peer-reviewed publications. Trusted by some of the nation's largest employers, states, and health plans, we've empowered over a million individuals on their journey to improved health, showcasing our dedication to expanding access to care. At 2Morrow, we're committed to using innovative technology and research to drive impactful change and expand access to care. For more information, please visit Deanna Waters 2Morrow [email protected] Visit us on social media: LinkedIn Facebook Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
15-05-2025
- Health
- Yahoo
New DiMe Seal Sets Benchmarks for Digital Health Products
Digital Medicine Society (DiMe) and Elevance Health collaborate to evaluate and elevate digital health software products BOSTON, May 15, 2025 /PRNewswire/ -- The Digital Medicine Society (DiMe) and Elevance Health have teamed up to simplify identifying trustworthy digital health products. The "DiMe Seal" (launched last year) is awarded to digital health software products (DHSPs) based on an assessment of usability, privacy and security, and evidence. This collaboration allows us to further assess DHSPs with a clinical component. Elevance Health will provide a clinical evidence assessment. DiMe will award its distinguished "DiMe Seal" to DHSPs that meet all its evaluation requirements. Each benchmark reflects a core value that users, healthcare providers, and payers expect from a trusted product. Annual reviews will ensure ongoing compliance with the latest industry standards and guidelines. With over 350,000 health apps available, including more than 30,000 for clinicians and healthcare administrators, it is increasingly difficult to identify high-quality, trustworthy options. A consumer-focused approach is needed to drive robust adoption of healthcare technologies. The DiMe Seal addresses this challenge by recognizing DHSPs that meet rigorous standards and are most likely to improve health outcomes. Elevance Health's clinical evidence assessment is anchored in the Evidence DEFINED framework, created through a collaboration led by DiMe in 2023, to help payers and other organizations quickly determine the clinical value of digital health products. "To improve health outcomes at scale, it is critical for the digital health industry to move in an evidence-based direction. Elevance Health is proud to lead in the clinical evaluation of digital health software products," said Jordan Silberman, MD, PhD, Director of Clinical Analytics & Research, Elevance Health. "Strategic partnerships and responsible innovation are essential for fostering trust in these products among individuals and their care teams." "Clinical evidence assessment is often lengthy and costly. By embedding this critical component into the DiMe Seal process, we help developers address clinical needs and validate their products' value," said Doug Mirsky, Vice President, Digital Medicine Society. "With Elevance Health's rigorous clinical assessment, it becomes simpler for health systems, clinicians, and users to adopt effective new technologies." To start the process to obtain a DiMe Seal, or to learn more, click here. About the Digital Medicine Society: DiMe is a global non-profit and the professional home for all members of the digital medicine community. Together, we tackle the toughest digital medicine challenges, develop clinical-quality resources on a technology timeline, and deliver these actionable resources to the field via open-source channels and educational programs. Media Contact: Carla English, press@ View original content to download multimedia: SOURCE Digital Medicine Society (DiMe) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
